One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report 2026

One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Overview

• One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics market size has reached to $1.49 billion in 2025 • Expected to grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.4% • Growth Driver: Rising Infectious Disease Prevalence Driving The Market Growth Due To Rapid And Accurate Pathogen Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market?

One-hour Low-cost multipurpose highly Efficient System (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics is a rapid, sensitive, and cost-effective molecular diagnostic platform that uses CRISPR-Cas technology to detect specific nucleic acid sequences from pathogens or genetic targets. The system leverages CRISPR-mediated cleavage and signal amplification to provide accurate results in approximately one hour. It helps to deliver fast, affordable, and precise molecular diagnostics for disease detection, surveillance, and personalized healthcare. The main product typs of one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics are kits, instruments, reagents, and other product types. Kits refer to ready-to-use sets containing all necessary materials and reagents for conducting CRISPR-based diagnostic tests efficiently. These solutions are supported by various service types, including sample collection and preparation services, assay development and validation services, data interpretation and reporting services, and quality control and assurance services. They are used across multiple applications, such as infectious disease diagnosis, oncology, genetic disease screening, and other applications, and cater to different end-users, including hospitals and clinics, diagnostic laboratories, research institutes, and other end-users.

What Is The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Growth Forecast?

The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market size is expected to see exponential growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to expansion of point of care molecular testing, rising demand for rapid pathogen detection, growth in personalized diagnostics, increased crispr clinical adoption, broader field deployable testing. Major trends in the forecast period include rapid crispr based diagnostic assays, point of care crispr testing kits, multiplex gene detection panels, portable molecular crispr platforms, low cost nucleic acid detection kits.

Global One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Segmentation

1) By Product Type: Kits; Instruments; Reagents; Other Product Types 2) By Service Type: Sample Collection And Preparation Services; Assay Development And Validation Services; Data Interpretation And Reporting Services; Quality Control And Assurance Services 3) By Application: Infectious Disease Diagnosis; Oncology; Genetic Disease Screening; Other Applications 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End-Users Subsegments: 1) By Kits: Single Target Diagnostic Kits; Multiplex Diagnostic Kits; Point Of Care Testing Kits; Laboratory Use Diagnostic Kits; Disease Specific Diagnostic Kits 2) By Instruments: Benchtop Diagnostic Instruments; Portable Diagnostic Devices; Automated Detection Systems; Sample Preparation Instruments; Integrated Analysis Platforms 3) By Reagents: Enzyme Based Reagents; Nucleic Acid Extraction Reagents; Amplification Reaction Reagents; Detection And Reporting Reagents; Sample Stabilization Reagents 4) By Other Product Types: Consumables And Accessories; Quality Control Materials; Calibration Standards; Disposable Testing Components; Supporting Laboratory Supplies

What Are The Drivers Of The One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market?

The rising prevalence of infectious diseases is expected to propel the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market going forward. Infectious diseases are illnesses resulting from the invasion of the body by harmful microorganisms, which can be transmitted through contact, air, water, or vectors. Infectious diseases are increasing due to urbanization and high population density, which facilitate faster transmission of pathogens. HOLMES CRISPR Diagnostics helps detect infectious diseases by using CRISPR-Cas enzymes to identify specific genetic sequences of pathogens quickly and accurately, enabling rapid, sensitive, and point-of-care diagnosis. For instance, in February 2024, according to GOV.UK, a UK-based government department, cases of tuberculosis (TB) in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the rising prevalence of infectious diseases is driving the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market. The rising use of precision medicine is expected to propel the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market going forward. Precision medicine involves delivering personalized healthcare by considering a person’s genetic, environmental, and lifestyle factors. The adoption of precision medicine is increasing due to advancements in genomics, which allow doctors to identify genetic variations and develop targeted treatments, improving patient outcomes. The HOLMES CRISPR diagnostics system helps precision medicine by rapidly and accurately detecting specific genetic mutations or pathogens in a patient’s DNA or RNA, enabling tailored treatments and early interventions based on an individual’s unique genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the rising use of precision medicine is driving the growth of the hybrid oligonucleotide-linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market. The rising healthcare expenditure is expected to propel the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market going forward. Healthcare expenditure refers to the funds used for prevention, diagnosis, treatment, and management of illnesses and health conditions. Healthcare expenditure is increasing due to the rising prevalence of chronic diseases, which require ongoing treatment and medical care. Increasing healthcare spending facilitates the use of HOLMES CRISPR diagnostics by funding advanced testing technologies and improving diagnostic accessibility. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market.

Key Players In The Global One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market

Major companies operating in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Bio‑Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, OraSure Technologies Inc., Molbio Diagnostics Pvt. Ltd., New England Biolabs Inc., Horizon Discovery Group plc, Mammoth Biosciences, Synthego Corporation, Binx Health Inc., Sherlock Biosciences Inc., Caspr Biotech, Tolo Biotechnology Co. Ltd., CrisprBits Private Limited, Scope Biosciences.

nan

nan

Regional Insights

North America was the largest region in the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market?

The one-hour low-cost multipurpose highly efficient system(HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market consists of revenues earned by entities by providing services such as rapid nucleic acid detection and analysis, molecular diagnostic testing, pathogen identification, genetic mutation screening, point-of-care diagnostic services, and clinical sample processing. The market value includes the value of related goods sold by the service provider or included within the service offering. The one-hour low-cost multipurpose highly efficient system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market also includes sales of assay consumables, reaction chambers and cartridges, and associated hardware and software components. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report 2026?

The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.